John MacLeod Poses with a Smile

‘Cracking the Nut’ on RAS Mutations

Scientists have spent 35 years seeking ways to disable RAS, a gene that’s mutated in many cancer types. Now, they’re moving closer to solutions. An article by  TARA HAELLE PUBLISHED August 03, 2018 The fact that JOHN MACLEOD'S colorectal cancer expresses a RAS gene mutation has limited his treatment options. - PHOTO BY KONNOR J … Continue reading ‘Cracking the Nut’ on RAS Mutations

News Radio 690 W.P.T.F icon

News radio 680 WPTF on Pancreatic Cancer

Rick and Donna Martinez have a morning live interview show featuring conversations with community personalities and leaders about issues that impact you.  We are happy to share the March 1, 2018 radio podcast with our own Pancreatic Cancer Experts Channing Der, PhD and Kirsten Bryant, PhD. This interview discusses common perceptions of Pancreatic Cancer; Symptoms … Continue reading News radio 680 WPTF on Pancreatic Cancer

Dr. Channing Der smiles for the camera.

Merck’s ERK inhibitor shows promise in combo against resistant cancers

by Amirah Al Idrus | Feb 22, 2018  fiercebiotech.com One-fifth of patients in a phase 1 study responded to an investigational ERK inhibitor from Merck, bolstering hopes that this type of drug could be used effectively in combination with other cancer drugs. ERK is a cell signal that is believed to drive the growth of … Continue reading Merck’s ERK inhibitor shows promise in combo against resistant cancers

UNC Lineberger faculty, trainees advocate for federal support for research

Several UNC Lineberger Comprehensive Cancer Center faculty and trainees were in Washington D.C. Thursday as part of as the Rally for Medical Research, a national campaign that advocates for sustained and strong federal funding for medical research. The American Association for Cancer Research founded the annual event in 2013. AACR expected more than 300 scientists, … Continue reading UNC Lineberger faculty, trainees advocate for federal support for research

Der Lab members attend PanCAN Annual Meeting

Channing, Kirsten and Bjoern attended the Pancreatic Cancer Action Network Annual Scientific Meeting in San Diego, CA, August 18-21, 2016.  The theme for this meeting was Wage Hope 2020 with the goal of doubling the dismay 5-year survival rate for this deadly cancer.   This meeting was held jointly with the The Pancreatic Cancer Action … Continue reading Der Lab members attend PanCAN Annual Meeting

Der honored with Emmanuel Farber Distinguished Visiting Lectureship

Dr. Channing Der was honored as this year's Emmanuel Farber Distinguished Visiting Lecturer.  This special talk is a part of the University of Toronto Laboratory Medicine & Pathobiology weekly seminar.    Dr. Der spoke about Targeting RAS for cancer treatment.  See below for the history of this special lectureship. History of the Farber Distinguished Visiting Lecture … Continue reading Der honored with Emmanuel Farber Distinguished Visiting Lectureship